<DOC>
	<DOCNO>NCT00886353</DOCNO>
	<brief_summary>The purpose study define dose Phase II study investigate safety tolerability intravenous administration recombinant soluble human Angiotensin Converting Enzyme 2 healthy volunteer .</brief_summary>
	<brief_title>Safety Tolerability Study APN01 ( Recombinant Human Angiotensin Converting Enzyme 2 )</brief_title>
	<detailed_description>APN01-1-01 placebo control double blinded Phase I study composed single dose , dose escalation part follow multiple dosage part . The first four cohort ( four individual ) receive 100 , 200 , 400 800 µg/kg APN01 i.v . placebo . Cohorts 5 6 ( three individual ) receive three six i.v . APN01 administration daily , respectively . Planned dosage multiple dose part 400 µg/kg .</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Kidney Diseases</mesh_term>
	<criteria>Male female Age ≥18 year Use acceptable form birth control Willing comply study protocol No significant background illness Signed informed consent form Significant hematological , renal , hepatic , metabolic , psychiatric pulmonary disease . Heart disease elevate blood pressure . Any significant disease could interfere subject 's ability complete protocol History alcohol drug abuse Abnormal urinalysis Pregnant lactate female subject Use anticoagulant antihypertensive drug , particularly drug interfere reninangiotensinaldosterone system , Obesity anorexia ( BMI &lt; 18 &gt; 30 ) History malignancy , except basal cell carcinoma skin , Known history human immunodeficiency virus ( HIV ) , hepatitis B hepatitis C infection positive serology test study screening procedure ( except indicate immunization ) Participation clinical trial within last 30 day Any follow laboratory abnormality : WBC 15 % outside normal limit Hemoglobin 15 % outside normal limit Platelets 15 % outside normal limit Aspartate transferase ( AST ) alanine transferase ( ALT ) 15 % outside normal limit Alkaline phosphatase 15 % outside normal limit Urea 15 % outside normal limit Creatinine 15 % outside normal limit .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2009</verification_date>
	<keyword>RAS</keyword>
	<keyword>ACE2</keyword>
	<keyword>Cardiovascular</keyword>
	<keyword>Pulmonary</keyword>
	<keyword>Angiotensin II</keyword>
	<keyword>Angiotensin 1-7</keyword>
</DOC>